Abstract: Provided are a method for performing a PCR reaction using a PCR reaction system, a PCR reaction system, as well as a composition, a freeze-dried powder, and a diluent. The PCR reaction method includes: subjecting the piston to the first and second movement processings, to subject the diluent entering the injection chamber, the pyrolysis freeze-dried powder, and the sample to a first mixing processing; subjecting the first mixture to a pyrolysis processing; subjecting the piston to the third and fourth movement processings, to subject the pyrolysis liquid entering the injection chamber and the remaining diluent to a second mixing processing; subjecting the piston to the fifth and sixth movement processings, to allow the second mixture to enter the injection chamber and undergone a third mixing processing with the freeze-dried powder of the reverse transcriptase and the PCR raw materials; and subjecting the third mixture to a PCR amplification processing.

Abstract: Provided are a method for performing a PCR reaction using a PCR reaction system, a PCR reaction system, as well as a composition, a freeze-dried powder, and a diluent. The PCR reaction method includes: subjecting the piston to the first and second movement processings, to subject the diluent entering the injection chamber, the pyrolysis freeze-dried powder, and the sample to a first mixing processing; subjecting the first mixture to a pyrolysis processing; subjecting the piston to the third and fourth movement processings, to subject the pyrolysis liquid entering the injection chamber and the remaining diluent to a second mixing processing; subjecting the piston to the fifth and sixth movement processings, to allow the second mixture to enter the injection chamber and undergone a third mixing processing with the freeze-dried powder of the reverse transcriptase and the PCR raw materials; and subjecting the third mixture to a PCR amplification processing.

Abstract: Provided is a molecular detection system and a microfluidic kit adapted for the molecular detection system. The molecular detection system includes: a substrate; and a fixing apparatus; a driving apparatus; a detection apparatus; and a temperature control apparatus that are arranged on the substrate, the fixing apparatus is adapted to fix a container containing a sample to be detected; the driving apparatus is adapted to drive the container to preprocess the sample to be detected; the detection apparatus is adapted to detect the sample to be detected that has undergone the preprocessing; and the temperature control apparatus is adapted to regulate a temperature of the sample to be detected. The microfluidic kit includes: a box body having a reagent zone, a sample zone, and a reaction zone inside; and a microfluidic kit chip including a microfluidic pipe with a piercing member provided inside and facing a liquid outlet.

Abstract: Compositions, reactions mixtures, kits, and systems for detecting bacterial contamination are provided, as well as methods of using the same.

Abstract: Compositions, reactions mixtures, kits, and systems for detecting bacterial contamination are provided, as well as methods of using the same.

Abstract: Compositions, reactions mixtures, kits, and systems for detecting bacterial contamination are provided, as well as methods of using the same.

Abstract: Compositions, reactions mixtures, kits, and systems for detecting bacterial contamination are provided, as well as methods of using the same.

Abstract: Compounds represented by the formula 1: wherein each R individually is H, an aliphatic acyl group or an aromatic acyl group; A is selected from the group consisting of wherein X is selected from the group consisting of hydrogen, halo, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano and nitro; are used to treat or prevent arthritis including rheumatoid arthritis.

Abstract: Compounds represented by the formula 1: wherein each R individually is H, an aliphatic acyl group or an aromatic acyl group; A is selected from the group consisting of wherein X is selected from the group consisting of hydrogen, halo, alkoxy, alkyl, haloalkyl, alkenyl, haloalkenyl, alkynyl, amino, monoalkylamino, dialkylamino, cyano and nitro; are used to treat or prevent arthritis including rheumatoid arthritis.

Abstract: Disclosed is method for treating viral infections and compounds for use in such treatments. The method involves administering a pharmaceutical formulation including 3,5-dicaffeoylquinic acid or its analogs or derivatives to a patient.

Abstract: The invention provides a novel protein, PX3.101, which can be isolated from honey bee venom, antibodies against the polypeptide and nucleic acids encoding PX3.101 and fragments thereof. The invention also provides pharmaceutical compositions based upon PX3.101 polypeptide and methods for using same in the treatment of various diseases, including various inflammatory diseases such as rheumatoid arthritis.